Does Allergen-Specific Immunotherapy Prevent New Sensitizations in Childhood Allergic Airway Diseases?

Creative Commons License

Dilek E., Bag O., Altinoz S., ASİLSOY S., Ozturk A., Can D.

ASTIM ALLERJI IMMUNOLOJI, cilt.16, sa.1, ss.34-39, 2018 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.21911/aai.344
  • Dergi Adı: ASTIM ALLERJI IMMUNOLOJI
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.34-39
  • Anahtar Kelimeler: Childhood, asthma, allergic rhinitis, immunotherapy, new sensitizations
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective: Specific immunotherapy (SIT) is a well-established treatment method that is suggested to alter the natural course of the disease. Although the mechanisms remain unclear, recent studies have shown that allergen-specific immunotherapy may reduce the risk of new sensitizations. The aim of this study was to evaluate new sensitizations in children who underwent SIT for allergic airway diseases: allergic rhinitis, allergic asthma or both.